Literature DB >> 19250412

Multiple pilomatricomas and gliomatosis cerebri--a new association?

Tina Wachter-Giner1, Imke Bieber, Monika Warmuth-Metz, Eva-B Bröcker, Henning Hamm.   

Abstract

Pilomatricomas are benign skin tumors originating from hair follicle matrix cells. In 2% to 3.5% of cases they occur in multiplicity and then may be associated with genetic diseases, such as myotonic dystrophy Curschmann-Steinert, familial adenomatous polyposis (Gardner syndrome), and Rubinstein-Taybi syndrome. A 15-year-old boy treated with temozolomide and oxcarbazepine for gliomatosis cerebri with symptomatic epilepsy developed four firm cutaneous nodules on his face and right upper arm in the course of 1 year. All four tumors were excised under local anesthesia. Histological examination confirmed the clinical diagnosis of pilomatricomas. This is the first published case of a patient suffering from gliomatosis cerebri and developing multiple pilomatricomas. Whether this observation represents a new association or is a mere coincidence cannot be clarified at present.

Entities:  

Mesh:

Year:  2009        PMID: 19250412     DOI: 10.1111/j.1525-1470.2008.00827.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  Multiple eruptive pilomatricomas in a young woman with glioblastoma multiforme.

Authors:  S Harshatha; R Sivayogana; Adarsh Manuel; S Murugans
Journal:  Indian J Dermatol Venereol Leprol       Date:  2021 Jan-Feb       Impact factor: 2.545

Review 2.  Skin tumors in childhood.

Authors:  Henning Hamm; Peter H Höger
Journal:  Dtsch Arztebl Int       Date:  2011-05-20       Impact factor: 5.594

3.  [Anetodermic pilomatricoma. Uncommon variant of a common childhood adnexal tumor].

Authors:  F Karademir; A Kerstan; H Hamm
Journal:  Hautarzt       Date:  2014-01       Impact factor: 0.751

4.  Brain size regulations by cbp haploinsufficiency evaluated by in-vivo MRI based volumetry.

Authors:  Juan C Ateca-Cabarga; Alejandro Cosa; Vicente Pallarés; José P López-Atalaya; Ángel Barco; Santiago Canals; David Moratal
Journal:  Sci Rep       Date:  2015-11-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.